Momentum in favor of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

by DAN BioMarin Pharmaceutical Inc. ($BMRN) is resolving it’s latest consolidation to the updside. BioMarin Pharmaceutical Inc. is up 1.87% at $65.94 on a volume of 1,880,550 shares today.

BioMarin Pharmaceuticals (BMRN) has been in a tight volatility squeeze for the past several weeks. Today the stock closed above the upper Bollinger Band for the first time since it began consolidating in mid-July. Technical traders who like to trade volatility expansions will be watching this stock for a breakout above $67, which is current resistance for this stock.

52 Week Range $36.28-$71.56 Market Cap 9,238,562,671 Average Volume 1,161,352 Dividend Yield 0.00% Institutional Ownership 0.00% Insider Ownership: 1.00% Percentage of Float Short 3.60% Beta 1.20

BioMarin Pharmaceutical Inc. is above the 50 day moving average and above the 200 day moving average. These are bullish, bullish indicators respectively.

BioMarin Pharmaceutical Inc. Biomarin Pharmaceutical, Inc., develops and commercializes pharmaceuticals for serious diseases and medical conditions.

Articles